Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 81/100

Becton Dickinson and Co at Leerink Partners Global Healthcare Conference Transcript

Feb 28, 2019 / 03:00PM GMT
Release Date Price: $242.56 (-0.60%)
Richard S. Newitter
SVB Leerink LLC, Research Division - MD, Medical Supplies & Devices and Senior Analyst

All right. I think we're going to get started. If you could all take your seats. Thank you very much. My name is Rich Newitter, Medical Device Analyst here at SVB Leerink. Thanks for joining us this morning. We're very fortunate to have with us presenting from Becton, Dickinson, Chris Reidy, Executive Vice President, Chief Financial Officer. Chris, thank you for joining us.

Christopher R. Reidy
Becton, Dickinson and Company - Executive VP, CFO & Chief Administrative Officer

My pleasure. Glad to be here.

Questions & Answers

Richard S. Newitter
SVB Leerink LLC, Research Division - MD, Medical Supplies & Devices and Senior Analyst

So a lot of things I want to cover, but I thought maybe a good high-level place to start might be, you just recently issued a few weeks ago your -- I'm sorry, you didn't issue, you reiterated your financial outlook for fiscal year 2019. Maybe -- and you sounded,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot